Gemmer Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
NIM
RJA
FHA
WAM
AG
Gemmer Asset Management's HQL Position: Q1 2019 in Review
Gemmer Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q1 2019, closing a stake of 22 shares.
Gemmer Asset Management first reported a position in HQL in Q1 2014 and held it in 19 quarters. The position peaked at $12K in Q2 2018. 56 funds tracked by Wall St. Rank hold HQL as of Q1 2019.
- Gemmer Asset Management reported no remaining abrdn Life Sciences Investors position as of Q1 2019 after selling out during the quarter.
- Gemmer Asset Management sold 22 abrdn Life Sciences Investors shares in Q1 2019.
- Gemmer Asset Management first reported a position in abrdn Life Sciences Investors in Q1 2014 and held it in 19 quarters.
- Gemmer Asset Management's abrdn Life Sciences Investors position peaked at $12K in Q2 2018.
- 56 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2019.
Based on Gemmer Asset Management's 13F filing for Q1 2019, filed 17 Apr 2019.